NTLA
Intellia Therapeutics, Inc. · Healthcare
President and CEO John M Leonard sold $314K of Intellia Therapeutics, Inc.
Sold$314,485
$9.21Price
34,146Shares
−3%Stake
What NTLA did after the filing
- The stock from Thu, Jan 8 open, $10.72
- +22.8%
- S&P 500, same days
- −0.9%
Measured over 30 trading days, to the Feb 23 close.
Traded Mon, Jan 5. Filed Wed, Jan 7, 4:05 PM ET, after the close. Returns use the Jan 8 open and the Feb 23 close. Not investment advice.